Announce Date | 05/06/2025 |
EPS Normalized Actual | $4.04 (Beat by $0.44) |
EPS GAAP Actual | $4.04 (Beat by $0.44) |
Revenue Actual | $1.21505B |
Revenue Surprise | Beat by $1215.05M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $4.91466 |
EPS GAAP Estimate | $4.91466 |
Revenue Estimate | $1.226B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 17.72 | 5.89 | 12.45892 | 24.07206 | 3 |
Dec 2028 | 22.76 | 4.59 | 21.24772 | 24.13668 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.67 | 3.67 | 1.21505B | 10.68% | 1215.05M |
FQ4 2024 (Dec 2024) | 3.47 | 3.47 | 1.45467B | 33.68% | 1454.67M |
FQ3 2024 (Sep 2024) | 13.01 | 13.01 | 1.45047B | 22.55% | 1450.47M |
FQ2 2024 (Jun 2024) | 4.36 | 4.36 | 1.26068B | 27.65% | 1260.68M |
FQ4 2009 (Dec 2009) | -0.0395 | -0.0395 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | 4.81 | 4.81 | 1.08526B | 17.39% | 1085.26M |
FQ4 2023 (Dec 2023) | 6.95 | 6.95 | 0.964685B | -5.28% | 964.69M |
FQ3 2023 (Sep 2023) | 5.03 | 5.03 | 1.12337B | -5.83% | 1123.37M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
4.91466
Consensus Revenue Estimates
1.226B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.84 | -- | 2.79655 | 5.26613 | 6 |
FQ3 2027 (Sep 2027) | 3.33 | -- | 2.42513 | 4.56673 | 3 |
FQ2 2027 (Jun 2027) | 3.33 | -- | 2.42513 | 4.56673 | 3 |
FQ1 2027 (Mar 2027) | 3.29 | -- | 2.396 | 4.51187 | 6 |
FQ4 2026 (Oct 2026) | 5.01798 | -- | 4.17864 | 6.11864 | 3 |
FQ3 2026 (Jul 2026) | 5.02358 | -- | 4.1833 | 6.12546 | 3 |
FQ2 2026 (Jun 2026) | 6.25695 | -- | 5.78301 | 7.07059 | 3 |
FQ1 2026 (Mar 2026) | 6.26673 | 41.44 | 5.79205 | 7.08164 | 3 |
FQ4 2025 (Oct 2025) | 5.09836 | 31.94 | 4.24557 | 6.21665 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.55B | -- | 1.23B | 1.99B | 4 |
FQ3 2027 (Sep 2027) | 1.54B | -- | 1.22B | 1.98B | 4 |
FQ2 2027 (Jun 2027) | 1.54B | -- | 1.21B | 1.97B | 4 |
FQ1 2027 (Mar 2027) | 1.53B | -- | 1.21B | 1.96B | 4 |
FQ4 2026 (Oct 2026) | 1.25B | -- | 1.09B | 1.46B | 2 |
FQ3 2026 (Jul 2026) | 1.24B | -- | 1.08B | 1.45B | 2 |
FQ2 2026 (Jun 2026) | 1.18B | -- | 1.11B | 1.3B | 2 |
FQ1 2026 (Mar 2026) | 1.18B | -3.06 | 1.11B | 1.3B | 2 |
FQ4 2025 (Oct 2025) | 1.25B | -16.56 | 1.09B | 1.46B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.67 | 3.67 | 100% | |
FQ4 2024 (Dec 2024) | 3.47 | 3.47 | 100% | |
FQ3 2024 (Sep 2024) | 13.01 | 13.01 | 100% | |
FQ2 2024 (Jun 2024) | 4.36 | 4.36 | 100% | |
FQ4 2009 (Dec 2009) | -0.0395 | -0.0395 | 100% | |
FQ1 2024 (Mar 2024) | 4.81 | 4.81 | 100% | |
FQ4 2023 (Dec 2023) | 6.95 | 6.95 | 100% | |
FQ3 2023 (Sep 2023) | 5.03 | 5.03 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.22B | $1215.05M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.45B | $1454.67M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.45B | $1450.47M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.26B | $1260.68M | 100% |
FQ4 2009 (Dec 2009) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $1.09B | $1085.26M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.96B | $964.69M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.12B | $1123.37M | 100% |